NDUFAF4: Potential Drug Targets for The Treatment of Motor Neuron Loss

Target Name: NDUFAF4

NCBI ID: G29078

NDUFAF4

NDUFAF4: Potential Drug Targets for The Treatment of Motor Neuron Loss

Nudoff-Down syndrome (NDUFAF4) is a rare autosomal recessive disorder that is characterized by the progressive loss of motor neurons in the spinal cord. The disorder is caused by a deficiency of the neurotransmitter dopamine, which is essential for the proper functioning of motor neurons. The loss of dopamine leads to a progressive muscle weakness and wasting, which can have a significant impact on an individual's quality of life.

The hormone-regulated proliferation-associated protein of 20 kDa (NDUFAF4) is a protein that is expressed in the brain and is involved in the regulation of neuronal proliferation. The protein is named after Dr. Nudoff-Down, who first described the disorder in 1988.

NDUFAF4 function

NDUFAF4 is a key regulator of neuronal proliferation in the brain. It is involved in the proliferation of neurons that are associated with the dopamine system. The protein is expressed in the brain and is involved in the development and maintenance of normal neuronal growth and function.

NDUFAF4 plays a critical role in the regulation of neuronal proliferation by controlling the levels of the chemical messenger molecule cyclic DNA damage (CDD). CDD is a normal byproduct of DNA replication that can cause damage to DNA if it accumulates in excess.

NDUFAF4 helps to regulate the level of CDD by controlling the activity of the enzyme responsible for its production, called DNA damage-inducible GFP (DDI-GFP). DDI-GFP is a transcription factor that is activated by CDD and promotes the production of GFP.

NDUFAF4 also regulates the level of CDD by controlling the activity of the transcription factor p21. p21 is a tumor suppressor gene that is often activated by CDD and promotes the production of CD47, a protein that can inhibit the growth and survival of cancer cells.

NDUFAF4 function in the treatment of NDUFAF4

The lack of effective treatments for NDUFAF4 has made it a difficult disorder to treat. However, recent studies have identified potential drug targets for NDUFAF4.

One potential drug target for NDUFAF4 is the protein itself. NDUFAF4 has been shown to be involved in the regulation of neuronal proliferation and has been shown to play a critical role in the development and maintenance of normal neuronal growth and function.

Another potential drug target for NDUFAF4 is the enzyme responsible for its production, DNA damage-inducible GFP (DDI-GFP). DDI-GFP is a transcription factor that is activated by CDD and can be used to label neurons that have been damaged by CDD.

In addition, NDUFAF4 has also been shown to be involved in the regulation of the growth and survival of cancer cells, which could make it an attractive target for cancer therapy.

Conclusion

NDUFAF4 is a hormone-regulated proliferation-associated protein of 20 kDa that is involved in the regulation of neuronal proliferation. The disorder is caused by a deficiency of the neurotransmitter dopamine and leads to the progressive loss of motor neurons in the spinal cord.

The hormone-regulated proliferation-associated protein of 20 kDa (NDUFAF4) is a potential drug target for the treatment of NDUFAF4. Studies have identified the potential targets of NDUFAF4, including the protein itself, the enzyme responsible for its production, and NDUFAF4's role in the regulation of the growth and survival of cancer cells.

It is important to note that whileNDUFAF4 is a promising target for the treatment of NDUFAF4, further research is needed to understand its full potential and to develop safe and effective treatments.

Protein Name: NADH:ubiquinone Oxidoreductase Complex Assembly Factor 4

Functions: Involved in the assembly of mitochondrial NADH:ubiquinone oxidoreductase complex (complex I) (PubMed:18179882, PubMed:28853723). May be involved in cell proliferation and survival of hormone-dependent tumor cells. May be a regulator of breast tumor cell invasion

The "NDUFAF4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NDUFAF4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets